0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Transfusion Diagnosis for Donor Market Research Report 2026
Published Date: 2026-01-14
|
Report Code: QYRE-Auto-11E17652
Home | Market Reports | Health| Reproductive Health
Global Transfusion Diagnosis for Donor Market Research Report 2024
BUY CHAPTERS

Global Transfusion Diagnosis for Donor Market Research Report 2026

Code: QYRE-Auto-11E17652
Report
2026-01-14
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Transfusion Diagnosis for Donor Market Size

The global Transfusion Diagnosis for Donor market was valued at US$ 4500 million in 2025 and is anticipated to reach US$ 6546 million by 2032, at a CAGR of 5.5% from 2026 to 2032.

Transfusion Diagnosis for Donor Market

Transfusion Diagnosis for Donor Market

The gross profit margin of major companies in the industry is between 50% – 70%.
Transfusion Diagnosis for Donors refers to the critical medical screening and testing process performed on blood donors to ensure the safety and compatibility of blood products. This includes mandatory screening for transfusion-transmitted infections (TTIs) such as HIV, Hepatitis B and C, and Syphilis using Nucleic Acid Testing (NAT) and ELISA. It also encompasses blood group serology (ABO/Rh typing) and cross-matching. These procedures are fundamental to modern hemovigilance, ensuring every blood unit meets stringent clinical safety standards to prevent adverse reactions in recipients.
The industrial chain begins upstream with providers of biological raw materials (antigens, antibodies, enzymes), precision optical sensors, microfluidic chips, and high-purity reagents. The midstream consists of manufacturers of automated blood screening platforms, molecular diagnostic systems, and immunoassays. Downstream applications include national and regional blood centers, hospital blood banks, and plasma collection stations. The chain is supported by cold-chain logistics providers and regulatory bodies. Service providers offer calibration, system maintenance, and integrated blood management software to track blood units from collection to clinical transfusion, ensuring full traceability and safety.
The market for transfusion diagnosis is witnessing a significant shift toward automated and molecular-based testing to minimize the "window period" of infection detection. Increasing global healthcare expenditures and aging populations are driving the demand for safe blood supplies. A key trend is the integration of Nucleic Acid Testing (NAT) with traditional serology to enhance sensitivity. Furthermore, the adoption of Big Data and AI in blood management systems is optimizing inventory and reducing wastage. While stringent regulatory requirements pose a high entry barrier, the expansion of blood banking infrastructure in emerging economies provides substantial growth opportunities. Manufacturers are focusing on high-throughput systems that reduce manual errors while maintaining the highest levels of diagnostic accuracy and safety.
This report delivers a comprehensive overview of the global Transfusion Diagnosis for Donor market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Transfusion Diagnosis for Donor. The Transfusion Diagnosis for Donor market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Transfusion Diagnosis for Donor market comprehensively. Regional market sizes by Type, by Application, by Diagnostic Purpose, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Transfusion Diagnosis for Donor manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Transfusion Diagnosis for Donor Market Report

Report Metric Details
Report Name Transfusion Diagnosis for Donor Market
Accounted market size in 2025 US$ 4500 million
Forecasted market size in 2032 US$ 6546 million
CAGR 5.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Instruments
  • Kits and Reagents
Segment by Diagnostic Purpose
  • Blood Grouping & Typing Diagnostics
  • Infectious Disease Screening Diagnostics
Segment by Testing Method
  • Immunoassay-Based Diagnostics
  • Molecular Diagnostics
Segment by Application
  • Blood Banks
  • Blood Donation/Transfusion Centers
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Grifols, F. Hoffmann-La Roche, Abbott, Bio-Rad Laboratories, Werfen, QuidelOrtho Corporation, AliveDx Holdings Finance, BAG Diagnostics GmbH, Diasorin, Prestige Diagnostics, Atlas Medical GmbH, Lorne Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Diagnostic Purpose, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Transfusion Diagnosis for Donor companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Transfusion Diagnosis for Donor Market growing?

Ans: The Transfusion Diagnosis for Donor Market witnessing a CAGR of 5.5% during the forecast period 2026-2032.

What is the Transfusion Diagnosis for Donor Market size in 2032?

Ans: The Transfusion Diagnosis for Donor Market size in 2032 will be US$ 6546 million.

Who are the main players in the Transfusion Diagnosis for Donor Market report?

Ans: The main players in the Transfusion Diagnosis for Donor Market are Grifols, F. Hoffmann-La Roche, Abbott, Bio-Rad Laboratories, Werfen, QuidelOrtho Corporation, AliveDx Holdings Finance, BAG Diagnostics GmbH, Diasorin, Prestige Diagnostics, Atlas Medical GmbH, Lorne Laboratories

What are the Application segmentation covered in the Transfusion Diagnosis for Donor Market report?

Ans: The Applications covered in the Transfusion Diagnosis for Donor Market report are Blood Banks, Blood Donation/Transfusion Centers, Others

What are the Type segmentation covered in the Transfusion Diagnosis for Donor Market report?

Ans: The Types covered in the Transfusion Diagnosis for Donor Market report are Instruments, Kits and Reagents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transfusion Diagnosis for Donor Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Instruments
1.2.3 Kits and Reagents
1.3 Market by Diagnostic Purpose
1.3.1 Global Transfusion Diagnosis for Donor Market Size Growth Rate by Diagnostic Purpose: 2021 vs 2025 vs 2032
1.3.2 Blood Grouping & Typing Diagnostics
1.3.3 Infectious Disease Screening Diagnostics
1.4 Market by Testing Method
1.4.1 Global Transfusion Diagnosis for Donor Market Size Growth Rate by Testing Method: 2021 vs 2025 vs 2032
1.4.2 Immunoassay-Based Diagnostics
1.4.3 Molecular Diagnostics
1.5 Market by Application
1.5.1 Global Transfusion Diagnosis for Donor Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Blood Banks
1.5.3 Blood Donation/Transfusion Centers
1.5.4 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Transfusion Diagnosis for Donor Market Perspective (2021–2032)
2.2 Global Transfusion Diagnosis for Donor Growth Trends by Region
2.2.1 Global Transfusion Diagnosis for Donor Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Transfusion Diagnosis for Donor Historic Market Size by Region (2021–2026)
2.2.3 Transfusion Diagnosis for Donor Forecasted Market Size by Region (2027–2032)
2.3 Transfusion Diagnosis for Donor Market Dynamics
2.3.1 Transfusion Diagnosis for Donor Industry Trends
2.3.2 Transfusion Diagnosis for Donor Market Drivers
2.3.3 Transfusion Diagnosis for Donor Market Challenges
2.3.4 Transfusion Diagnosis for Donor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transfusion Diagnosis for Donor Players by Revenue
3.1.1 Global Top Transfusion Diagnosis for Donor Players by Revenue (2021–2026)
3.1.2 Global Transfusion Diagnosis for Donor Revenue Market Share by Players (2021–2026)
3.2 Global Top Transfusion Diagnosis for Donor Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Transfusion Diagnosis for Donor Revenue
3.4 Global Transfusion Diagnosis for Donor Market Concentration Ratio
3.4.1 Global Transfusion Diagnosis for Donor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transfusion Diagnosis for Donor Revenue in 2025
3.5 Global Key Players of Transfusion Diagnosis for Donor Head Offices and Areas Served
3.6 Global Key Players of Transfusion Diagnosis for Donor, Products and Applications
3.7 Global Key Players of Transfusion Diagnosis for Donor, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Transfusion Diagnosis for Donor Breakdown Data by Type
4.1 Global Transfusion Diagnosis for Donor Historic Market Size by Type (2021–2026)
4.2 Global Transfusion Diagnosis for Donor Forecasted Market Size by Type (2027–2032)
5 Transfusion Diagnosis for Donor Breakdown Data by Application
5.1 Global Transfusion Diagnosis for Donor Historic Market Size by Application (2021–2026)
5.2 Global Transfusion Diagnosis for Donor Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Transfusion Diagnosis for Donor Market Size (2021–2032)
6.2 North America Transfusion Diagnosis for Donor Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Transfusion Diagnosis for Donor Market Size by Country (2021–2026)
6.4 North America Transfusion Diagnosis for Donor Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transfusion Diagnosis for Donor Market Size (2021–2032)
7.2 Europe Transfusion Diagnosis for Donor Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Transfusion Diagnosis for Donor Market Size by Country (2021–2026)
7.4 Europe Transfusion Diagnosis for Donor Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Transfusion Diagnosis for Donor Market Size (2021–2032)
8.2 Asia-Pacific Transfusion Diagnosis for Donor Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Transfusion Diagnosis for Donor Market Size by Region (2021–2026)
8.4 Asia-Pacific Transfusion Diagnosis for Donor Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Transfusion Diagnosis for Donor Market Size (2021–2032)
9.2 Latin America Transfusion Diagnosis for Donor Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Transfusion Diagnosis for Donor Market Size by Country (2021–2026)
9.4 Latin America Transfusion Diagnosis for Donor Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transfusion Diagnosis for Donor Market Size (2021–2032)
10.2 Middle East & Africa Transfusion Diagnosis for Donor Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Transfusion Diagnosis for Donor Market Size by Country (2021–2026)
10.4 Middle East & Africa Transfusion Diagnosis for Donor Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Details
11.1.2 Grifols Business Overview
11.1.3 Grifols Transfusion Diagnosis for Donor Introduction
11.1.4 Grifols Revenue in Transfusion Diagnosis for Donor Business (2021–2026)
11.1.5 Grifols Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Transfusion Diagnosis for Donor Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Transfusion Diagnosis for Donor Business (2021–2026)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Transfusion Diagnosis for Donor Introduction
11.3.4 Abbott Revenue in Transfusion Diagnosis for Donor Business (2021–2026)
11.3.5 Abbott Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Details
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Transfusion Diagnosis for Donor Introduction
11.4.4 Bio-Rad Laboratories Revenue in Transfusion Diagnosis for Donor Business (2021–2026)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Werfen
11.5.1 Werfen Company Details
11.5.2 Werfen Business Overview
11.5.3 Werfen Transfusion Diagnosis for Donor Introduction
11.5.4 Werfen Revenue in Transfusion Diagnosis for Donor Business (2021–2026)
11.5.5 Werfen Recent Development
11.6 QuidelOrtho Corporation
11.6.1 QuidelOrtho Corporation Company Details
11.6.2 QuidelOrtho Corporation Business Overview
11.6.3 QuidelOrtho Corporation Transfusion Diagnosis for Donor Introduction
11.6.4 QuidelOrtho Corporation Revenue in Transfusion Diagnosis for Donor Business (2021–2026)
11.6.5 QuidelOrtho Corporation Recent Development
11.7 AliveDx Holdings Finance
11.7.1 AliveDx Holdings Finance Company Details
11.7.2 AliveDx Holdings Finance Business Overview
11.7.3 AliveDx Holdings Finance Transfusion Diagnosis for Donor Introduction
11.7.4 AliveDx Holdings Finance Revenue in Transfusion Diagnosis for Donor Business (2021–2026)
11.7.5 AliveDx Holdings Finance Recent Development
11.8 BAG Diagnostics GmbH
11.8.1 BAG Diagnostics GmbH Company Details
11.8.2 BAG Diagnostics GmbH Business Overview
11.8.3 BAG Diagnostics GmbH Transfusion Diagnosis for Donor Introduction
11.8.4 BAG Diagnostics GmbH Revenue in Transfusion Diagnosis for Donor Business (2021–2026)
11.8.5 BAG Diagnostics GmbH Recent Development
11.9 Diasorin
11.9.1 Diasorin Company Details
11.9.2 Diasorin Business Overview
11.9.3 Diasorin Transfusion Diagnosis for Donor Introduction
11.9.4 Diasorin Revenue in Transfusion Diagnosis for Donor Business (2021–2026)
11.9.5 Diasorin Recent Development
11.10 Prestige Diagnostics
11.10.1 Prestige Diagnostics Company Details
11.10.2 Prestige Diagnostics Business Overview
11.10.3 Prestige Diagnostics Transfusion Diagnosis for Donor Introduction
11.10.4 Prestige Diagnostics Revenue in Transfusion Diagnosis for Donor Business (2021–2026)
11.10.5 Prestige Diagnostics Recent Development
11.11 Atlas Medical GmbH
11.11.1 Atlas Medical GmbH Company Details
11.11.2 Atlas Medical GmbH Business Overview
11.11.3 Atlas Medical GmbH Transfusion Diagnosis for Donor Introduction
11.11.4 Atlas Medical GmbH Revenue in Transfusion Diagnosis for Donor Business (2021–2026)
11.11.5 Atlas Medical GmbH Recent Development
11.12 Lorne Laboratories
11.12.1 Lorne Laboratories Company Details
11.12.2 Lorne Laboratories Business Overview
11.12.3 Lorne Laboratories Transfusion Diagnosis for Donor Introduction
11.12.4 Lorne Laboratories Revenue in Transfusion Diagnosis for Donor Business (2021–2026)
11.12.5 Lorne Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Transfusion Diagnosis for Donor Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Instruments
 Table 3. Key Players of Kits and Reagents
 Table 4. Global Transfusion Diagnosis for Donor Market Size Growth Rate by Diagnostic Purpose (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Key Players of Blood Grouping & Typing Diagnostics
 Table 6. Key Players of Infectious Disease Screening Diagnostics
 Table 7. Global Transfusion Diagnosis for Donor Market Size Growth Rate by Testing Method (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Key Players of Immunoassay-Based Diagnostics
 Table 9. Key Players of Molecular Diagnostics
 Table 10. Global Transfusion Diagnosis for Donor Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 11. Global Transfusion Diagnosis for Donor Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 12. Global Transfusion Diagnosis for Donor Market Size by Region (US$ Million), 2021–2026
 Table 13. Global Transfusion Diagnosis for Donor Market Share by Region (2021–2026)
 Table 14. Global Transfusion Diagnosis for Donor Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 15. Global Transfusion Diagnosis for Donor Market Share by Region (2027–2032)
 Table 16. Transfusion Diagnosis for Donor Market Trends
 Table 17. Transfusion Diagnosis for Donor Market Drivers
 Table 18. Transfusion Diagnosis for Donor Market Challenges
 Table 19. Transfusion Diagnosis for Donor Market Restraints
 Table 20. Global Transfusion Diagnosis for Donor Revenue by Players (US$ Million), 2021–2026
 Table 21. Global Transfusion Diagnosis for Donor Market Share by Players (2021–2026)
 Table 22. Global Top Transfusion Diagnosis for Donor Players by Tier (Tier 1, Tier 2, and Tier 3), based on Transfusion Diagnosis for Donor Revenue, 2025
 Table 23. Ranking of Global Top Transfusion Diagnosis for Donor Companies by Revenue (US$ Million) in 2025
 Table 24. Global 5 Largest Players Market Share by Transfusion Diagnosis for Donor Revenue (CR5 and HHI), 2021–2026
 Table 25. Global Key Players of Transfusion Diagnosis for Donor, Headquarters and Area Served
 Table 26. Global Key Players of Transfusion Diagnosis for Donor, Products and Applications
 Table 27. Global Key Players of Transfusion Diagnosis for Donor, Date of General Availability (GA)
 Table 28. Mergers and Acquisitions, Expansion Plans
 Table 29. Global Transfusion Diagnosis for Donor Market Size by Type (US$ Million), 2021–2026
 Table 30. Global Transfusion Diagnosis for Donor Revenue Market Share by Type (2021–2026)
 Table 31. Global Transfusion Diagnosis for Donor Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 32. Global Transfusion Diagnosis for Donor Revenue Market Share by Type (2027–2032)
 Table 33. Global Transfusion Diagnosis for Donor Market Size by Application (US$ Million), 2021–2026
 Table 34. Global Transfusion Diagnosis for Donor Revenue Market Share by Application (2021–2026)
 Table 35. Global Transfusion Diagnosis for Donor Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 36. Global Transfusion Diagnosis for Donor Revenue Market Share by Application (2027–2032)
 Table 37. North America Transfusion Diagnosis for Donor Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 38. North America Transfusion Diagnosis for Donor Market Size by Country (US$ Million), 2021–2026
 Table 39. North America Transfusion Diagnosis for Donor Market Size by Country (US$ Million), 2027–2032
 Table 40. Europe Transfusion Diagnosis for Donor Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Europe Transfusion Diagnosis for Donor Market Size by Country (US$ Million), 2021–2026
 Table 42. Europe Transfusion Diagnosis for Donor Market Size by Country (US$ Million), 2027–2032
 Table 43. Asia-Pacific Transfusion Diagnosis for Donor Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Asia-Pacific Transfusion Diagnosis for Donor Market Size by Region (US$ Million), 2021–2026
 Table 45. Asia-Pacific Transfusion Diagnosis for Donor Market Size by Region (US$ Million), 2027–2032
 Table 46. Latin America Transfusion Diagnosis for Donor Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 47. Latin America Transfusion Diagnosis for Donor Market Size by Country (US$ Million), 2021–2026
 Table 48. Latin America Transfusion Diagnosis for Donor Market Size by Country (US$ Million), 2027–2032
 Table 49. Middle East & Africa Transfusion Diagnosis for Donor Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 50. Middle East & Africa Transfusion Diagnosis for Donor Market Size by Country (US$ Million), 2021–2026
 Table 51. Middle East & Africa Transfusion Diagnosis for Donor Market Size by Country (US$ Million), 2027–2032
 Table 52. Grifols Company Details
 Table 53. Grifols Business Overview
 Table 54. Grifols Transfusion Diagnosis for Donor Product
 Table 55. Grifols Revenue in Transfusion Diagnosis for Donor Business (US$ Million), 2021–2026
 Table 56. Grifols Recent Development
 Table 57. F. Hoffmann-La Roche Company Details
 Table 58. F. Hoffmann-La Roche Business Overview
 Table 59. F. Hoffmann-La Roche Transfusion Diagnosis for Donor Product
 Table 60. F. Hoffmann-La Roche Revenue in Transfusion Diagnosis for Donor Business (US$ Million), 2021–2026
 Table 61. F. Hoffmann-La Roche Recent Development
 Table 62. Abbott Company Details
 Table 63. Abbott Business Overview
 Table 64. Abbott Transfusion Diagnosis for Donor Product
 Table 65. Abbott Revenue in Transfusion Diagnosis for Donor Business (US$ Million), 2021–2026
 Table 66. Abbott Recent Development
 Table 67. Bio-Rad Laboratories Company Details
 Table 68. Bio-Rad Laboratories Business Overview
 Table 69. Bio-Rad Laboratories Transfusion Diagnosis for Donor Product
 Table 70. Bio-Rad Laboratories Revenue in Transfusion Diagnosis for Donor Business (US$ Million), 2021–2026
 Table 71. Bio-Rad Laboratories Recent Development
 Table 72. Werfen Company Details
 Table 73. Werfen Business Overview
 Table 74. Werfen Transfusion Diagnosis for Donor Product
 Table 75. Werfen Revenue in Transfusion Diagnosis for Donor Business (US$ Million), 2021–2026
 Table 76. Werfen Recent Development
 Table 77. QuidelOrtho Corporation Company Details
 Table 78. QuidelOrtho Corporation Business Overview
 Table 79. QuidelOrtho Corporation Transfusion Diagnosis for Donor Product
 Table 80. QuidelOrtho Corporation Revenue in Transfusion Diagnosis for Donor Business (US$ Million), 2021–2026
 Table 81. QuidelOrtho Corporation Recent Development
 Table 82. AliveDx Holdings Finance Company Details
 Table 83. AliveDx Holdings Finance Business Overview
 Table 84. AliveDx Holdings Finance Transfusion Diagnosis for Donor Product
 Table 85. AliveDx Holdings Finance Revenue in Transfusion Diagnosis for Donor Business (US$ Million), 2021–2026
 Table 86. AliveDx Holdings Finance Recent Development
 Table 87. BAG Diagnostics GmbH Company Details
 Table 88. BAG Diagnostics GmbH Business Overview
 Table 89. BAG Diagnostics GmbH Transfusion Diagnosis for Donor Product
 Table 90. BAG Diagnostics GmbH Revenue in Transfusion Diagnosis for Donor Business (US$ Million), 2021–2026
 Table 91. BAG Diagnostics GmbH Recent Development
 Table 92. Diasorin Company Details
 Table 93. Diasorin Business Overview
 Table 94. Diasorin Transfusion Diagnosis for Donor Product
 Table 95. Diasorin Revenue in Transfusion Diagnosis for Donor Business (US$ Million), 2021–2026
 Table 96. Diasorin Recent Development
 Table 97. Prestige Diagnostics Company Details
 Table 98. Prestige Diagnostics Business Overview
 Table 99. Prestige Diagnostics Transfusion Diagnosis for Donor Product
 Table 100. Prestige Diagnostics Revenue in Transfusion Diagnosis for Donor Business (US$ Million), 2021–2026
 Table 101. Prestige Diagnostics Recent Development
 Table 102. Atlas Medical GmbH Company Details
 Table 103. Atlas Medical GmbH Business Overview
 Table 104. Atlas Medical GmbH Transfusion Diagnosis for Donor Product
 Table 105. Atlas Medical GmbH Revenue in Transfusion Diagnosis for Donor Business (US$ Million), 2021–2026
 Table 106. Atlas Medical GmbH Recent Development
 Table 107. Lorne Laboratories Company Details
 Table 108. Lorne Laboratories Business Overview
 Table 109. Lorne Laboratories Transfusion Diagnosis for Donor Product
 Table 110. Lorne Laboratories Revenue in Transfusion Diagnosis for Donor Business (US$ Million), 2021–2026
 Table 111. Lorne Laboratories Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. Transfusion Diagnosis for Donor Picture
 Figure 2. Global Transfusion Diagnosis for Donor Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Transfusion Diagnosis for Donor Market Share by Type: 2025 vs 2032
 Figure 4. Instruments Features
 Figure 5. Kits and Reagents Features
 Figure 6. Global Transfusion Diagnosis for Donor Market Size Comparison by Diagnostic Purpose (US$ Million), 2021–2032
 Figure 7. Blood Grouping & Typing Diagnostics Features
 Figure 8. Infectious Disease Screening Diagnostics Features
 Figure 9. Global Transfusion Diagnosis for Donor Market Size Comparison by Testing Method (US$ Million), 2021–2032
 Figure 10. Immunoassay-Based Diagnostics Features
 Figure 11. Molecular Diagnostics Features
 Figure 12. Global Transfusion Diagnosis for Donor Market Size by Application (US$ Million), 2021–2032
 Figure 13. Global Transfusion Diagnosis for Donor Market Share by Application: 2025 vs 2032
 Figure 14. Blood Banks Case Studies
 Figure 15. Blood Donation/Transfusion Centers Case Studies
 Figure 16. Others Case Studies
 Figure 17. Transfusion Diagnosis for Donor Report Years Considered
 Figure 18. Global Transfusion Diagnosis for Donor Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 19. Global Transfusion Diagnosis for Donor Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 20. Global Transfusion Diagnosis for Donor Market Share by Region: 2025 vs 2032
 Figure 21. Global Transfusion Diagnosis for Donor Market Share by Players in 2025
 Figure 22. Global Transfusion Diagnosis for Donor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 23. The Top 10 and 5 Players Market Share by Transfusion Diagnosis for Donor Revenue in 2025
 Figure 24. North America Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. North America Transfusion Diagnosis for Donor Market Share by Country (2021–2032)
 Figure 26. United States Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Canada Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Europe Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Europe Transfusion Diagnosis for Donor Market Share by Country (2021–2032)
 Figure 30. Germany Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. France Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. U.K. Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Italy Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Russia Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Ireland Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Asia-Pacific Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Asia-Pacific Transfusion Diagnosis for Donor Market Share by Region (2021–2032)
 Figure 38. China Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Japan Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. South Korea Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Southeast Asia Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. India Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Australia & New Zealand Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Latin America Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Latin America Transfusion Diagnosis for Donor Market Share by Country (2021–2032)
 Figure 46. Mexico Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Brazil Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Middle East & Africa Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Middle East & Africa Transfusion Diagnosis for Donor Market Share by Country (2021–2032)
 Figure 50. Israel Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 52. UAE Transfusion Diagnosis for Donor Market Size YoY Growth (US$ Million), 2021–2032
 Figure 53. Grifols Revenue Growth Rate in Transfusion Diagnosis for Donor Business (2021–2026)
 Figure 54. F. Hoffmann-La Roche Revenue Growth Rate in Transfusion Diagnosis for Donor Business (2021–2026)
 Figure 55. Abbott Revenue Growth Rate in Transfusion Diagnosis for Donor Business (2021–2026)
 Figure 56. Bio-Rad Laboratories Revenue Growth Rate in Transfusion Diagnosis for Donor Business (2021–2026)
 Figure 57. Werfen Revenue Growth Rate in Transfusion Diagnosis for Donor Business (2021–2026)
 Figure 58. QuidelOrtho Corporation Revenue Growth Rate in Transfusion Diagnosis for Donor Business (2021–2026)
 Figure 59. AliveDx Holdings Finance Revenue Growth Rate in Transfusion Diagnosis for Donor Business (2021–2026)
 Figure 60. BAG Diagnostics GmbH Revenue Growth Rate in Transfusion Diagnosis for Donor Business (2021–2026)
 Figure 61. Diasorin Revenue Growth Rate in Transfusion Diagnosis for Donor Business (2021–2026)
 Figure 62. Prestige Diagnostics Revenue Growth Rate in Transfusion Diagnosis for Donor Business (2021–2026)
 Figure 63. Atlas Medical GmbH Revenue Growth Rate in Transfusion Diagnosis for Donor Business (2021–2026)
 Figure 64. Lorne Laboratories Revenue Growth Rate in Transfusion Diagnosis for Donor Business (2021–2026)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India